AGRX Market Cap History
Below is a table of the AGRX market cap history going back to 8/13/2014:

Date AGRX Market Cap
8/13/2014116.95M
11/13/2014119.37M
3/16/2015214.23M
5/11/2015257.77M
8/12/2015200.44M
11/9/2015185.47M
3/4/2016183.35M
5/5/2016166.71M
8/5/2016201.56M
11/4/2016206.48M
3/10/201769.06M
5/5/201797.08M
7/27/2017132.51M
11/3/2017157.94M
3/9/2018126.72M
5/4/201893.16M
8/2/20189.21M
11/1/201831.73M
3/11/201962.23M
5/2/201964.74M
7/31/201951.94M
8/5/201996.51M
10/28/201926.80M
2/18/2020275.05M
5/1/2020241.58M
8/7/2020231.34M
11/9/2020252.69M
2/24/2021274.28M
4/30/2021163.29M
7/23/2021107.88M
10/29/202196.27M
3/25/202235.67M
5/9/20228.04M

Also see: AGRX Shares Outstanding History
and AGRX YTD Return
AGRX Historical Market Cap:
-29.23% CAGR
AGRX Historical Market Cap: +-29.23% CAGR

Mouse over chart for data details
8/13/2014 ...5/9/2022
Agile Therapeutics is a women's healthcare company. Co.'s primary product candidate, Twirla, is a once-weekly prescription combination hormonal contraceptive patch. It delivers a dose of estrogen that is consistent with commonly prescribed combined hormonal contraceptives. Co.'s pipeline consists of two classes of product candidates: Co.'s potential product pipeline consists of two types of product candidates: a progestin-only contraceptive patch and potential Twirla line extensions. These potential product candidates are designed to address market needs and provide additional non-daily contraceptive options. Including AG200-15 Extended Regimen, AG200-SmP, and AG200-15 ER SmP. We show 33 historical shares outstanding datapoints in our AGRX shares outstanding history coverage, used to compute AGRX market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AGRX market cap history over the course of time is important for investors interested in comparing AGRX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AGRX versus a peer is one thing; comparing AGRX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AGRX can fluctuate over the course of history. With this page we aim to empower investors researching AGRX by allowing them to research the AGRX market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree AGRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Agile Therapeutics (AGRX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AGTC Market Cap History
AGTI Market Cap History
AHCO Market Cap History
AHPI Market Cap History
AIKI Market Cap History
AIMT Market Cap History
AIPT Market Cap History
AIQ Market Cap History
AITB Market Cap History
AKAO Market Cap History
More Healthcare companies »

 

AGRX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.